SCHEMBL27329709

SCHEMBL27329709

CC(C)[C@@H](C(=O)O)N1CCCC2(CN(C(=O)OC(C)(C)C)C2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
USP30 Q70CQ3 1/20 0.40
TSHR P16473 2/20 0.39
ALOX15 P16050 1/20 0.39
HRH3 Q9Y5N1 2/20 0.35
ATM Q13315 2/20 0.35
HTT P42858 2/20 0.34
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
THRB P10828 1/20 0.33
USP2 O75604 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NR1H2 P55055 1/20 0.32
EPHX2 P34913 1/20 0.32
HPGD P15428 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27330073 0.93 USP30 (0.48) GRIN2BGRIN2CUSP30TSHRALOX15
SCHEMBL27330081 0.93 USP30 (0.48) GRIN2BGRIN2CUSP30TSHRALOX15
SCHEMBL27330087 0.93 USP30 (0.48) GRIN2BGRIN2CUSP30TSHRALOX15
SCHEMBL27330342 0.93 USP30 (0.43) GRIN2BGRIN2CUSP30TSHRALOX15
SCHEMBL27329706 0.92 GRIN2B (0.45) GRIN2BGRIN2CUSP30TSHRALOX15
SCHEMBL27329326 0.91 TSHR (0.43) GRIN2BGRIN2CUSP30TSHRALOX15
SCHEMBL23295356 0.87 USP30 (0.50) GRIN2BGRIN2CUSP30TSHRALOX15
SCHEMBL23297828 0.87 USP30 (0.50) GRIN2BGRIN2CUSP30TSHRALOX15
SCHEMBL23295358 0.87 USP30 (0.50) GRIN2BGRIN2CUSP30TSHRALOX15
SCHEMBL23297826 0.87 USP30 (0.50) GRIN2BGRIN2CUSP30TSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532503-A1 HALOINDOLE MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2025-04-09 EP disclosed
CN-119301132-A Halogenated indole macrocyclic compounds for the treatment of cancer 豪夫迈·罗氏有限公司 2025-01-10 CN disclosed
WO-2023232776-A1 HALOINDOLE MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2023-12-07 WO disclosed
WO-2023232776-A1 HALOINDOLE MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2023-12-07 WO disclosed